Frontiers in Psychiatry (Apr 2022)

Clinical and Genetic Correlates of Bipolar Disorder With Childhood-Onset Attention Deficit Disorder

  • Nicolas A. Nunez,
  • Brandon J. Coombes,
  • Francisco Romo-Nava,
  • David J. Bond,
  • Jennifer Vande Voort,
  • Paul E. Croarkin,
  • Nicole Leibman,
  • Manuel Gardea Resendez,
  • Marin Veldic,
  • Hannah Betcher,
  • Balwinder Singh,
  • Colin Colby,
  • Alfredo Cuellar-Barboza,
  • Miguel Prieto,
  • Katherine M. Moore,
  • Aysegul Ozerdem,
  • Susan L. McElroy,
  • Mark A. Frye,
  • Joanna M. Biernacka,
  • Joanna M. Biernacka

DOI
https://doi.org/10.3389/fpsyt.2022.884217
Journal volume & issue
Vol. 13

Abstract

Read online

Background:Bipolar disorder (BD) with co-occurring attention deficit-hyperactivity disorder (ADHD) is associated with an unfavorable course of illness. We aimed to identify potential clinical and genetic correlates of BD with and without ADHD.MethodsAmong patients with BD (N = 2,198) enrolled in the Mayo Clinic Bipolar Biobank we identified those with ADHD diagnosed in childhood (BD+cADHD; N = 350), those with adult-onset attention deficit symptoms (BD+aAD; N = 254), and those without ADHD (N = 1,594). We compared the groups using linear or logistic regression adjusting for age, sex, and recruitment site. For genotyped patients (N = 1,443), logistic regression was used to compare ADHD and BD polygenic risk scores (PRSs) between the BD groups, as well as to non-BD controls (N = 777).ResultsCompared to the non-ADHD BD group, BD+cADHD patients were younger, more often men and had a greater number of co-occurring anxiety and substance use disorders (all p < 0.001). Additionally, BD+cADHD patients had poorer responses to lithium and lamotrigine (p = 0.005 and p = 0.007, respectively). In PRS analyses, all BD patient subsets had greater genetic risk for BD and ADHD when compared to non-BD controls (p < 0.001 in all comparisons). BD+cADHD patients had a higher ADHD-PRS than non-ADHD BD patients (p = 0.012). However, BD+aAD patients showed no evidence of higher ADHD-PRS than non-ADHD BD patients (p = 0.38).ConclusionsBD+cADHD was associated with a greater number of comorbidities and reduced response to mood stabilizing treatments. The higher ADHD PRS for the BD+cADHD group may reflect a greater influence of genetic factors on early presentation of ADHD symptoms.

Keywords